Latest Asx Announcements News

Platinum Capital Limited has pulled its proposed scheme of arrangement due to insufficient shareholder support but will proceed with an on-market buy-back. Meanwhile, L1 Capital pushes for management control and board renewal.

Race Oncology’s Phase 1b/2 trial of RC110 bisantrene for relapsed or refractory acute myeloid leukemia has demonstrated a 40% response rate, exceeding expectations and offering new hope for difficult-to-treat patients.

Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.

X2M Connect Limited’s X2MO securities have been suspended from ASX trading due to non-compliance with listing rules, raising questions about the company’s regulatory standing and next steps.

Chimeric Therapeutics has progressed its CHM CDH17 CAR-T cell therapy to dose level 2 in its Phase 1/2 trial, showing promising early anti-tumor activity and a strong safety profile in gastrointestinal and neuroendocrine cancers.

Sequoia Financial Group has launched a dedicated AFSL Governance Committee to bolster oversight across its licenses, appointing former ASIC Commissioner Danielle Press as Independent Chair.

BirdDog Technology Limited offers shareholders a voluntary off-market buy-back at 7 cents per share, a significant premium to recent trading prices, as it prepares for delisting from the ASX.

Forrestania Resources Limited has had its trading suspension lifted following the announcement of a proposed acquisition, signaling a pivotal moment for the mining explorer.

Cobre Limited’s CBEO securities have been suspended from trading pending regulatory compliance, raising questions about the company’s next steps and investor impact.

Winchester Energy Limited has resumed trading on the ASX following confirmation that it now meets director requirements under the Corporations Act. This development ends a trading suspension tied to governance compliance.

Latitude 66 Limited has agreed to sell its 17.5% interest in the Greater Duchess Copper Gold Joint Venture to Carnaby Resources for A$6 million, combining cash and shares. This strategic move frees up capital for Lat66 to focus on its exploration projects in Western Australia and Finland.

Raptis Group has entered a facilitation agreement to source funding for the Sterling Residences Broadbeach project, potentially earning up to $16 million in commission fees upon completion and unit settlements.